UnitedHealth Group (NYSE:UNH) PT Raised to $562.00

UnitedHealth Group (NYSE:UNH) had its target price lifted by analysts at Deutsche Bank Aktiengesellschaft from $545.00 to $562.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential upside of 12.15% from the company’s previous close.

Several other equities research analysts also recently issued reports on UNH. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Barclays lifted their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Price Performance

NYSE:UNH opened at $501.13 on Friday. UnitedHealth Group has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm has a fifty day simple moving average of $488.63 and a 200 day simple moving average of $515.17. The stock has a market capitalization of $462.01 billion, a PE ratio of 30.63, a P/E/G ratio of 1.35 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the firm posted $6.26 EPS. The company’s quarterly revenue was up 8.6% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group will post 27.74 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Institutional Trading of UnitedHealth Group

Institutional investors have recently added to or reduced their stakes in the stock. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Robbins Farley bought a new stake in UnitedHealth Group in the third quarter valued at approximately $25,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $31,000. Finally, NewSquare Capital LLC lifted its stake in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.